Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors
Noëlle van Egmond, Verena M. Straub, Mario van der Stelt
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 441-463
Open Access | Times Cited: 81

Showing 26-50 of 81 citing articles:

Identifying FAAH Inhibitors as New Therapeutic Options for the Treatment of Chronic Pain through Drug Repurposing
Anca Zanfirescu, Georgiana Nițulescu, Dragoș Paul Mihai, et al.
Pharmaceuticals (2021) Vol. 15, Iss. 1, pp. 38-38
Open Access | Times Cited: 21
Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment
Andrew F. Scheyer, Farhana Yasmin, Saptarnab Naskar, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 37-53
Closed Access | Times Cited: 15
CB1 allosteric modulators and their therapeutic potential in CNS disorders
Catharine A. Mielnik, Vincent Lam, Ruth A. Ross
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 106, pp. 110163-110163
Closed Access | Times Cited: 21
Cannabinoids in Late Life Parkinson’s Disease and Dementia: Biological Pathways and Clinical Challenges
Alana C. Costa, Helena Passarelli Giroud Joaquim, João Francisco Cordeiro Pedrazzi, et al.
Brain Sciences (2022) Vol. 12, Iss. 12, pp. 1596-1596
Open Access | Times Cited: 14
Chemical Probes to Control and Visualize Lipid Metabolism in the Brain
Jeroen M. Punt, Daan van der Vliet, Mario van der Stelt
Accounts of Chemical Research (2022) Vol. 55, Iss. 22, pp. 3205-3217
Open Access | Times Cited: 13
Cannabinoids: a class of unique natural products with unique pharmacology
Fabiana Piscitelli, Vincenzo Di Marzo
Rendiconti lincei. Scienze fisiche e naturali (2021) Vol. 32, Iss. 1, pp. 5-15
Closed Access | Times Cited: 17
Hexafluoroisopropyl Carbamates as Selective MAGL and Dual MAGL/FAAH Inhibitors: Biochemical and Physicochemical Properties
Maximilian Barth, Stefan Rudolph, Jan Kampschulze, et al.
ChemMedChem (2022) Vol. 17, Iss. 9
Open Access | Times Cited: 11
FAAH served a key membrane-anchoring and stabilizing role for NLRP3 protein independently of the endocannabinoid system
Yangyang Zhu, Hao Zhang, Huawei Mao, et al.
Cell Death and Differentiation (2022) Vol. 30, Iss. 1, pp. 168-183
Open Access | Times Cited: 11
Roadmap for the expression of canonical and extended endocannabinoid system receptors and metabolic enzymes in peripheral organs of preclinical animal models
Jose J. Rosado‐Franco, A. L. Ellison, Cory J. White, et al.
Physiological Reports (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 2
Fluorescence-Based Enzyme Activity Assay: Ascertaining the Activity and Inhibition of Endocannabinoid Hydrolytic Enzymes
Pierangela Ciuffreda, Ornella Xynomilakis, Silvana Casati, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7693-7693
Open Access | Times Cited: 2
Cannabinoid receptor gene CNR1 is downregulated in subcortical brain samples and upregulated in blood samples of individuals with schizophrenia: A participant data systematic meta‐analysis
Stav Bloch Priel, Assif Yitzhaky, David Gurwitz, et al.
European Journal of Neuroscience (2023) Vol. 58, Iss. 6, pp. 3540-3554
Open Access | Times Cited: 6
Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain
Yingfang He, Uwe Grether, Marco F. Taddio, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114750-114750
Open Access | Times Cited: 9
Endocannabinoid Degradation Enzyme Inhibitors as Potential Antipsychotics: A Medicinal Chemistry Perspective
Giuseppe Felice Mangiatordi, Maria Maddalena Cavalluzzi, Pietro Delre, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 469-469
Open Access | Times Cited: 5
Functional Variation in the FAAH Gene Is Directly Associated with Subjective Well-Being and Indirectly Associated with Problematic Alcohol Use
Lisa Bornscheuer, Andreas Lundin, Yvonne Forsell, et al.
Genes (2023) Vol. 14, Iss. 9, pp. 1826-1826
Open Access | Times Cited: 5
Activity-Based Photoacoustic Probes for Detection of Disease Biomarkers beyond Oncology
Michael C. Lee, Kayla Landers, Jefferson Chan
ACS Bio & Med Chem Au (2023) Vol. 3, Iss. 3, pp. 223-232
Open Access | Times Cited: 4
Novel Pyrazolopyridine Inhibitors of Monoacylglycerol Lipase for the Treatment of Neurodegenerative Diseases and Neuroinflammation
Gérard Rossé
ACS Medicinal Chemistry Letters (2024)
Open Access | Times Cited: 1
Circulating endocannabinoid levels in SARS-CoV-2 infection and their potential role in the inflammatory response
María Velasco, María Posada-Ayala, Elia Pérez‐Fernández, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Ferroptosis in Renal Cancer Therapy: A Narrative Review of Drug Candidates
Lingyan Yu, Yuyueyang Qiu, Xiangmin Tong
Cancers (2024) Vol. 16, Iss. 18, pp. 3131-3131
Open Access | Times Cited: 1
Concentration and Activation Biresponsive Strategy in One Analysis System with Simultaneous Use of G4 Structure-specific Signal Probe and Enzyme-catalyzed Reaction
Yushu Li, Chun-Feng Feng, Hao Chen, et al.
Analytica Chimica Acta (2024) Vol. 1329, pp. 343246-343246
Closed Access | Times Cited: 1
FAAH inhibitor URB597 shows anti‐hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF1 agonist mediated visceral hypersensitivity in male rats
Muriel Larauche, Agata Mulak, Chrysanthy Ha, et al.
Neurogastroenterology & Motility (2024)
Open Access | Times Cited: 1
Mechanism of N6-Methyladenosine Modification in the Pathogenesis of Depression
Zhuohang Xian, Liangchen Tian, Zai‐Fu Yao, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 1
Exploration of (R)-[11C]YH168 as a PET tracer for imaging monoacylglycerol lipase in the brain: from mice to non-human primates
Yingfang He, Ming‐Qiang Zheng, Jiwei Gu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Open Access | Times Cited: 1
The Endocannabinoid System as a Target for Neuroprotection/Neuroregeneration in Perinatal Hypoxic–Ischemic Brain Injury
Andrea Duranti, Gorane Beldarrain, Antonia Álvarez, et al.
Biomedicines (2022) Vol. 11, Iss. 1, pp. 28-28
Open Access | Times Cited: 7
Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy?
Ahmet Onay, Abdülselam Ertaş, Veysel Süzerer, et al.
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 570-587
Open Access | Times Cited: 9
Plasmatic endocannabinoids are decreased in subjects with ultra‐high risk of psychosis
Helena Passarelli Giroud Joaquim, Alana C. Costa, Cícero A. C. Pereira, et al.
European Journal of Neuroscience (2021) Vol. 55, Iss. 4, pp. 1079-1087
Closed Access | Times Cited: 8

Scroll to top